Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05992350 · ClinicalTrials.gov registry record
Garmin PACT (Physical Activity Tracking in Type 1 Diabetes Using Garmin Vivosmart)
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Terminated
- Registry status
- 45
- Enrollment target
NCT05992350: Clinical Trial study, sponsored by Children's Mercy Hospital Kansas City.
NCT05992350 is a clinical trial that was terminated before completion, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05992350 was terminated before completion, sponsored by Children's Mercy Hospital Kansas City.
- TERMINATED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The goal of this observational study is to test the Garmin Vivosmart in children and youth (8-21) with Type 1 Diabetes (T1D) and their parents. The main questions it aims to answer are: * Does the Garmin Vivosmart increase physical activity (PA)? * Does the Garmin Vivosmart improve T1D status Participants will: * Wear the Garmin Vivosmart (4 or higher) for a year * Complete surveys at the beginning, middle and end of participation asking about your T1D, T1D management, and PA * Parents of children will also complete similar surveys about T1D
Primary Outcome
Minutes per Day of MVPA
Interventions
- OTHER Garmin physical activity tracker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2024-01-16 |
| Est. Completion | 2025-06-18 |
Why NCT05992350 stopped before completion
NCT05992350 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Garmin physical activity tracker is the first listed.
NCT05992350 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05992350 about?
NCT05992350 is a clinical study titled "Garmin PACT (Physical Activity Tracking in Type 1 Diabetes Using Garmin Vivosmart)". The goal of this observational study is to test the Garmin Vivosmart in children and youth (8-21) with Type 1 Diabetes (T1D) and their parents. The main questions it aims to answer are: * Does the Garmin Vivosmart increase physical activity (PA)? * Does the Garmin Vivosmart improve T1D status Part...
What is the current status of trial NCT05992350?
This trial is currently terminated. The enrollment target is 45 participants. The study started on 2024-01-16. Estimated completion is 2025-06-18.
What interventions are being tested in trial NCT05992350?
The interventions under investigation include: Garmin physical activity tracker (OTHER).
Who is sponsoring clinical trial NCT05992350?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI